Iron sucrose
A medication used to treat iron deficiency anemia
Iron sucrose is a type of intravenous iron formulation used primarily in the treatment of iron deficiency anemia, particularly in patients with chronic kidney disease (CKD). It is known for its efficacy and safety profile, making it a preferred choice in clinical settings.
Medical uses[edit | edit source]
Iron sucrose is indicated for the treatment of iron deficiency anemia in patients with CKD, including those on hemodialysis, peritoneal dialysis, and those not on dialysis. It is also used in patients who cannot tolerate oral iron supplements or in whom oral iron is ineffective.
Mechanism of action[edit | edit source]
Iron sucrose works by replenishing body iron stores. It is composed of a polynuclear iron(III)-hydroxide core surrounded by sucrose molecules. This structure allows for the controlled release of iron, which is then incorporated into hemoglobin and myoglobin, essential components for oxygen transport and storage in the body.
Administration[edit | edit source]
Iron sucrose is administered intravenously, typically in a clinical setting. The dosage and frequency depend on the severity of the iron deficiency and the patient's overall health status. It is usually given as a slow injection or infusion to minimize the risk of adverse reactions.
Side effects[edit | edit source]
Common side effects of iron sucrose include hypotension, nausea, muscle cramps, and headache. Serious side effects are rare but can include anaphylaxis and other hypersensitivity reactions. Monitoring during administration is essential to manage any potential adverse effects promptly.
Advantages[edit | edit source]
Iron sucrose is favored for its rapid onset of action and effectiveness in increasing hemoglobin levels. It is also associated with a lower risk of severe allergic reactions compared to other intravenous iron formulations.
Disadvantages[edit | edit source]
Despite its benefits, iron sucrose requires intravenous administration, which can be inconvenient for some patients. It also necessitates monitoring for potential side effects during and after infusion.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
